Dec 17 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* POSITIVE RESULTS REAFFIRM PLANS TO ADVANCE ATL1102 FOR DMD TO PHASE IIB TRIAL
Dec 17 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* POSITIVE RESULTS REAFFIRM PLANS TO ADVANCE ATL1102 FOR DMD TO PHASE IIB TRIAL